Remove 2026 Remove Healthcare Provider Remove Patients
article thumbnail

Reaching Crucial Hispanic Patient Audiences

PM360

One fast-growing group in particular that requires a patient-centric and culturally relevant approach to marketing is the Hispanic audience, which is extremely diverse. The patient landscape continues to evolve. By 2026, the U.S. One immediate benefit of inclusive marketing—helping bridge barriers with healthcare providers.

article thumbnail

Specialty Treatments Require a New Approach to Affordability

PM360

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Insurance approval and distribution for specialty drugs can cause significant treatment delays up to three to four weeks for many patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why we need to support healthcare’s vital acceleration

pharmaphorum

Let me explain our four reasons for making healthcare a priority in greater detail: Firstly, healthcare’s historic acceleration means investments, both public and private, and revenues are likely to grow steadily. The Covid-19 pandemic made healthcare professionals focus on digital medicine, as they sought to treat patients remotely.

article thumbnail

Connected customer data: a golden opportunity for pharma marketers

pharmaphorum

Its ability to accelerate R&D programmes, energise real-time clinical decision making and sharpen connections between pharma organisations and clients is clear and they can combine to positively impact patient outcomes. billion by 2026, according to research by the Business Research Company. billion in 2021 to $9.23 References.

article thumbnail

Pharma’s pain from the Inflation Reduction Act will be felt well beyond the first 10 brands facing price cuts

Clarivate

Starting in 2026, the first ten self-administered Part D drugs in the law’s cross hairs will receive price cuts of 38%-79%. Meanwhile, patients will benefit from a new $2,000 cap on out-of-pocket costs (Read Clarivate’s Primer on the IRA for more details about the law’s reforms).

article thumbnail

Making Sense of the Latest Changes to the Market Access Landscape

PM360

However, Medicare will only be able to negotiate prices for 10 Part D drugs in 2026, another 15 Part D drugs in 2027, another 15 Part D and Part B drugs in 2028, and another 20 Part D and Part B drugs for 2029 and subsequent years. Impact Beyond Medicare The IRA won’t just impact negotiation with the government either. Reference: 1.

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare.

Retail 52